AR030016A1 - Derivados de 4-oxo-3,5-dihidro-4h-piridazino [4,5-b]indol-1-carboxamida, medicamento y composicion farmaceutica que comprenden a dichos derivados - Google Patents

Derivados de 4-oxo-3,5-dihidro-4h-piridazino [4,5-b]indol-1-carboxamida, medicamento y composicion farmaceutica que comprenden a dichos derivados

Info

Publication number
AR030016A1
AR030016A1 ARP000100304A ARP000100304A AR030016A1 AR 030016 A1 AR030016 A1 AR 030016A1 AR P000100304 A ARP000100304 A AR P000100304A AR P000100304 A ARP000100304 A AR P000100304A AR 030016 A1 AR030016 A1 AR 030016A1
Authority
AR
Argentina
Prior art keywords
derivatives
oxo
pharmaceutical composition
carboxamide
piridazino
Prior art date
Application number
ARP000100304A
Other languages
English (en)
Spanish (es)
Inventor
Jacques Froissant
Regine Bartsch-Li
Benoit Marabout
Mireille Sevrin
Frank Marguet
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of AR030016A1 publication Critical patent/AR030016A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ARP000100304A 1999-01-26 2000-01-25 Derivados de 4-oxo-3,5-dihidro-4h-piridazino [4,5-b]indol-1-carboxamida, medicamento y composicion farmaceutica que comprenden a dichos derivados AR030016A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9900805A FR2788776B1 (fr) 1999-01-26 1999-01-26 Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique

Publications (1)

Publication Number Publication Date
AR030016A1 true AR030016A1 (es) 2003-08-13

Family

ID=9541211

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP000100304A AR030016A1 (es) 1999-01-26 2000-01-25 Derivados de 4-oxo-3,5-dihidro-4h-piridazino [4,5-b]indol-1-carboxamida, medicamento y composicion farmaceutica que comprenden a dichos derivados

Country Status (11)

Country Link
US (1) US6451795B1 (https=)
EP (1) EP1149101B1 (https=)
JP (1) JP4574860B2 (https=)
AR (1) AR030016A1 (https=)
AT (1) ATE236905T1 (https=)
AU (1) AU3057800A (https=)
CO (1) CO5160255A1 (https=)
DE (1) DE60002043T2 (https=)
ES (1) ES2194696T3 (https=)
FR (1) FR2788776B1 (https=)
WO (1) WO2000044751A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2788696B1 (fr) * 1999-01-26 2004-03-05 Synthelabo Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2811990A1 (fr) * 2000-07-24 2002-01-25 Sanofi Synthelabo DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2833953B1 (fr) * 2001-12-21 2004-12-03 Sanofi Synthelabo DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2838124B1 (fr) * 2002-04-03 2004-05-28 Sanofi Synthelabo Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
GB0523506D0 (en) * 2005-11-18 2005-12-28 Hammersmith Imanet Ltd Novel in vivo imaging compounds
GB0818738D0 (en) * 2008-10-13 2008-11-19 Ge Healthcare Ltd Imaging neuroflammation
GB0905328D0 (en) * 2009-03-27 2009-05-13 Ge Healthcare Ltd Indole derivatives
EP2552891B1 (en) * 2010-03-26 2018-08-08 GE Healthcare Limited Tricyclic indole derivatives as pbr ligands
US9220795B2 (en) 2011-09-22 2015-12-29 Ge Healthcare Limited Indole derivatives
GB201312768D0 (en) * 2013-07-17 2013-08-28 Ge Healthcare Ltd Work-up procedure

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9109972D0 (en) * 1991-05-09 1991-07-03 Ici Plc Therapeutic compounds
GB9411955D0 (en) * 1994-06-15 1994-08-03 Merck Sharp & Dohme Therapeutic agents
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
FR2766823B1 (fr) 1997-07-30 1999-10-08 Synthelabo Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique

Also Published As

Publication number Publication date
JP4574860B2 (ja) 2010-11-04
CO5160255A1 (es) 2002-05-30
AU3057800A (en) 2000-08-18
ATE236905T1 (de) 2003-04-15
JP2002535406A (ja) 2002-10-22
ES2194696T3 (es) 2003-12-01
WO2000044751A1 (fr) 2000-08-03
EP1149101B1 (fr) 2003-04-09
EP1149101A1 (fr) 2001-10-31
DE60002043D1 (de) 2003-05-15
FR2788776B1 (fr) 2001-02-23
FR2788776A1 (fr) 2000-07-28
US6451795B1 (en) 2002-09-17
DE60002043T2 (de) 2004-02-19

Similar Documents

Publication Publication Date Title
AR012315A1 (es) Derivados de ditiolan y el uso de los mismos en la fabricacion de un medicamento.
MX9704777A (es) Compuestos espiro tetraciclicos, procedimiento para su preparacion y composiciones que los contienen.
CO5560573A2 (es) Derivados activos de amino-ftalazinona como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los contienen
AR013184A1 (es) Aminas heterociclicas espiroazobiciclicas, composicion farmaceutica, uso de dichas aminas para preparar medicamentos y metodo de tratamiento o profilaxis
AR022413A1 (es) Utilizacion de derivados de piridazino(4,5-b)indol-1-acetamida, para la preparacion de medicamentos destinados a las enfermedades del sistema nerviosocentral
PA8456901A1 (es) 2-aminopiridinas que contienen sustituyentes de anillos condensados
ES2084944T3 (es) Amidas terapeuticas.
ES2188584T3 (es) Derivados heterociclicos de amina.
AR025959A1 (es) DERIVADOS DE TER.-BUTIL-(7-METIL-IMIDAZO[1,2,a]PIRIDIN-3-IL)-AMINA, PROCEDIMIENTO PARA SU PREPARACION, MEDICAMENTOS QUE LOS CONTIENEN, SU USO PARA LAPREPARACION DE UN MEDICAMENTO PARA LA INHIBICION DE NO-SINTASA Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN
UY27457A1 (es) Derivados de 1,8-naftiridina y su uso para el tratamiento de la diabetes y trastornos relacionados
AR022860A1 (es) Derivados de camptotecina que poseen actividad antitumoral
AR045040A1 (es) Derivados de compuestos espiroazabiciclicos, composiciones farmaceuticas que los contienen y su uso en la preparacion de medicamentos
UY31334A1 (es) 3a,4,5,6,7,7a-hexahidro-3h-benzoimidazol y derivaods de 3a, 4,5,6,,7,7a-hexahidro-3-indol, enantiómeros, diastereoisómeros, sales farmacéuticamente aceptadas, mezclas, composiciones, preparaciones y aplicaciones de las mismas
AR031526A1 (es) Nuevas fenilpiperazinas, composiciones farmaceuticas que las contienen, metodos para preparar los compuestos y las composiciones y uso de los compuestos en la preparacion de un medicamento.
UY28536A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
AR030016A1 (es) Derivados de 4-oxo-3,5-dihidro-4h-piridazino [4,5-b]indol-1-carboxamida, medicamento y composicion farmaceutica que comprenden a dichos derivados
DE60001586D1 (de) Diphenyl-piperidin derivate
UY28356A1 (es) Derivados de benzimidazol, composiciones que los contienen, preparaciones de los mismos y sus usos
AR029758A1 (es) Un derivado del grupo a de las estreptograminas, su preparacion y las composiciones farmaceuticas que los contienen
AR024747A1 (es) Derivados de aminotiazoles, su preparacion y las composiciones farmaceuticas que los contienen.
ES2158861T3 (es) 4-imidometil-1-(2'-fenil-2'-oxoetil)-piperidinas como inhibidores de los receptores 5ht2 de la serotonina, su preparacion y sus aplicaciones terapeuticas.
ES2153019T3 (es) Derivados de benzo-dioxano, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
UY28535A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
UY28537A1 (es) Derivados de bencimidazol, composiciones que los contienen, preparacion y usos de los mismos.
UY26211A1 (es) Polimorfos de un diclorhidrato cristalino de azobiciclo (2.2.2)oct-3-ilamina y sus composiciones farmaceuticas

Legal Events

Date Code Title Description
FB Suspension of granting procedure